US 11110106
Sting agonists for treating bladder cancer and solid tumors
granted A61KA61K2039/505A61K2039/54
Quick answer
US patent 11110106 (Sting agonists for treating bladder cancer and solid tumors) held by VENENUM BIODESIGN, LLC expires Mon Sep 02 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- VENENUM BIODESIGN, LLC
- Grant date
- Tue Sep 07 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 02 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K2039/505, A61K2039/54, A61K2039/545, A61K31/519